A Trial of Tisotumab Vedotin in Cervical Cancer
Condition: Cervical Cancer Intervention: Drug: tisotumab vedotin Sponsors: Genmab; Seattle Genetics, Inc.; European Network of Gynaecological Oncological Trial Groups (ENGOT); Belgian Gynaecological Oncology Group; Gynecologic Oncology Group Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials